NCT00349180View on ClinicalTrials.gov

Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)

PHASE3CompletedINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

June 30, 2006

Conditions

Arthroplasty, Replacement, Hip

Interventions

DRUG

Enoxaparin sodium

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY